Js Capital Management LLC Mirati Therapeutics, Inc. Transaction History

Js Capital Management LLC

  • $199 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$144.0 - $179.73 $504,000 - $629,055
-3,500 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$158.92 - $221.61 $556,220 - $775,635
3,500 New
3,500 $600,000
Q2 2020

Aug 14, 2020
SELL
$72.01 - $120.39 $1.3 Million - $2.17 Million
-18,000 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$69.78 - $116.21 $1.26 Million - $2.09 Million
18,000 New
18,000 $1.38 Million

Others Institutions Holding MRTX

# of Institutions
16
Shares Held
3.57M
Call Options Held
0
Put Options Held
36.6K
View Full List

About Mirati Therapeutics, Inc.

MRTX Quotes by TradingView
  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Js Capital Management LLC Portfolio

Follow Js Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Js Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Js Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email